Antigen Information
General Information of This Antigen (ID: TAR0KQONX)
| Antigen Name | Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | TNFRSF17 |
|||||
| Gene ID | ||||||
| Synonym | BCM; BCMA; B-cell maturation protein;CD269 |
|||||
| Sequence |
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILWTCL
GLSLIISLAVFVLMFLLRKINSEPLKDEFKNTGSGLLGMANIDLEKSRTGDEIILPRGLE YTVEECTCEDCIKSKPKVDSDHCFPLPAMEEGATILVTTKTNDYCKSLPAALSATEIEKS ISAR Click to Show/Hide
|
|||||
| Function |
Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
| The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens | ||||
|---|---|---|---|---|
008 (BCMA)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC62-4
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
|
|
WO2024222841A1 ADC62
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
|
|
WO2024222841A1 ADC64-4
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Undisclosed |
|
|
WO2024222841A1 ADC64
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Undisclosed |
15B2GL
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
NZ761939B 15B2GL-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
Anti-BCMA antibody 15B2GL
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA 15B2GL-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA 15B2GL-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody 15B2WT
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA 15B2WT-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA 15B2WT-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody I09
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA I09-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA I09-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody J6M0
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA J6M0-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA J6M0-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody L15
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA L15-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA L15-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody M02
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA M02-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA M02-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody N22
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA N22-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA N22-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody P10
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA P10-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
|
|
Anti-BCMA P10-mcMMAF
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
Anti-BCMA antibody R347
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-BCMA R347-SG3249
[3]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
Anti-human BCMA IgG1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AMG 224
|
DM1 |
Microtubule (MT) |
4-[N-maleimidomethyl] cyclohexane-1-carboxylate (MCC) |
BCMA-A Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BCMA-A Antibody-Compound (X)
[4]
|
BCMA-A Antibody-Compound (X) payload |
Undisclosed |
BCMA-A Antibody-Compound (X) linker |
|
|
BCMA-A Antibody-Compound (XI)
[4]
|
BCMA-A Antibody-Compound (XI) payload |
Undisclosed |
BCMA-A Antibody-Compound (XI) linker |
|
|
BCMA-A Antibody-Compound (XIV)
[4]
|
BCMA-A Antibody-Compound (XIV) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIV) linker |
|
|
BCMA-A Antibody-Compound (XVIII)
[4]
|
BCMA-A Antibody-Compound (XVIII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XVIII) linker |
|
|
BCMA-A Antibody-Compound (Ie)
[4]
|
BCMA-A Antibody-Compound (Ie) payload |
Undisclosed |
BCMA-A Antibody-Compound (Ie) linker |
|
|
BCMA-A Antibody-Compound (XIX)
[4]
|
BCMA-A Antibody-Compound (XIX) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIX) linker |
|
|
BCMA-A Antibody-Compound (Ii)
[4]
|
BCMA-A Antibody-Compound (Ii) payload |
Undisclosed |
BCMA-A Antibody-Compound (Ii) linker |
|
|
BCMA-A Antibody-Compound (XLI)
[4]
|
BCMA-A Antibody-Compound (XLI) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLI) linker |
|
|
BCMA-A Antibody-Compound (XVI)
[4]
|
BCMA-A Antibody-Compound (XIX) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIX) linker |
|
|
BCMA-A Antibody-Compound (XL)
[4]
|
BCMA-A Antibody-Compound (XL) payload |
Undisclosed |
BCMA-A Antibody-Compound (XL) linker |
|
|
BCMA-A Antibody-Compound (XLIII)
[4]
|
BCMA-A Antibody-Compound (XLIII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLIII) linker |
|
|
BCMA-A Antibody-Compound (XLII)
[4]
|
BCMA-A Antibody-Compound (XLII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLII) linker |
|
|
BCMA-A Antibody-Compound (XV)
[4]
|
BCMA-A Antibody-Compound (XV) payload |
Undisclosed |
BCMA-A Antibody-Compound (XV) linker |
BCMA-Ab1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MEDI2228
|
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
Belantamab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
αBCMA-MC-I034
|
Amine-I034 |
IKZF1/3 |
MC |
|
|
Belan-DVA-I030
|
I030 |
IKZF1/3 |
MC-DVA-PABC |
|
|
Belan-VA-I034 (4)
|
I034 |
IKZF1/3 |
MC-VA |
|
|
Belan-VA-I034 (8)
|
I034 |
IKZF1/3 |
MC-VA |
|
|
Belantamab mafodotin
[5]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
|
|
Belantamab-Compound (Ia)
[6]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Belantamab-Compound (Ia) linker |
|
|
Belantamab-Compound (X)
[4]
|
Belantamab-Compound (X) payload |
Undisclosed |
Belantamab-Compound (X) linker |
|
|
Belantamab-Compound (XI)
[4]
|
Belantamab-Compound (XI) payload |
Undisclosed |
Belantamab-Compound (XI) linker |
|
|
Belantamab-Compound (XIV)
[4]
|
Belantamab-Compound (XIV) payload |
Undisclosed |
Belantamab-Compound (XIV) linker |
|
|
Belantamab-Compound (XVIII)
[4]
|
Belantamab-Compound (XVIII) payload |
Undisclosed |
Belantamab-Compound (XVIII) linker |
|
|
Belantamab-Compound (Ie)
[4]
|
Belantamab-Compound (Ie) payload |
Undisclosed |
Belantamab-Compound (Ie) linker |
|
|
Belantamab-Compound (XIX)
[4]
|
Belantamab-Compound (XIX) payload |
Undisclosed |
Belantamab-Compound (XIX) linker |
|
|
Belantamab-Compound (Ii)
[4]
|
Belantamab-Compound (Ii) payload |
Undisclosed |
Belantamab-Compound (Ii) linker |
|
|
Belantamab-Compound (XLI)
[4]
|
Belantamab-Compound (XLI) payload |
Undisclosed |
Belantamab-Compound (XLI) linker |
|
|
Belantamab-Compound (XVI)
[4]
|
Belantamab-Compound (XIX) payload |
Undisclosed |
Belantamab-Compound (XIX) linker |
|
|
Belantamab-Compound (XL)
[4]
|
Belantamab-Compound (XL) payload |
Undisclosed |
Belantamab-Compound (XL) linker |
|
|
Belantamab-Compound (XLIII)
[4]
|
Belantamab-Compound (XLIII) payload |
Undisclosed |
Belantamab-Compound (XLIII) linker |
|
|
Belantamab-Compound (XLII)
[4]
|
Belantamab-Compound (XLII) payload |
Undisclosed |
Belantamab-Compound (XLII) linker |
|
|
Belantamab-Compound (XV)
[4]
|
Belantamab-Compound (XV) payload |
Undisclosed |
Belantamab-Compound (XV) linker |
|
|
DB-1325
[7]
|
PDUP5 |
Undisclosed |
Undisclosed |
|
|
WO2024169913A1 ADC08-01-8
[8]
|
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Cit-PABC |
|
|
WO2024169913A1 ADC08-01-4
[8]
|
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Cit-PABC |
GENA-111
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
GENA-111-AF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
Humanized anti-BCMA mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
DXC009
|
Undisclosed |
Microtubule (MT) |
Undisclosed |
I09
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
I09-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
Ispectamab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Ispectamab debotansine
|
SC347 |
Microtubule (MT) |
Cys-12 ADC linker |
L15
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
L15-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
M02
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
M02-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
N22
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
N22-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
P10
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
P10-SG3249
[2]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
Pamlectabart
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Pamlectabart tismanitin
|
HDP 30.2115 |
RNA polymerase II |
Mal-Val-Ala-PAB |
SG1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SG1-Val-Cit-MMAF8
[10]
|
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
SG2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SG2-Val-Cit-MMAF8
[10]
|
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
SG3
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SG3-Val-Cit-MMAF8
[10]
|
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
STI-1260
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LN474-63
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
CN118079014A-linker-1 |
|
|
LN474-64
[11]
|
Monomethyl auristatin E |
Microtubule (MT) |
CN118079014A-linker-3 |
TNFRSF17 mAb1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN113549127A ADC-1
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-1-linker |
|
|
CN113549127A ADC-2
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-2-linker |
|
|
CN113549127A ADC-3
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-3-linker |
|
|
CN113549127A ADC-4
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-4-linker |
|
|
CN113549127A ADC-5
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-5-linker |
|
|
CN113549127A ADC-6
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-6-linker |
|
|
CN113549127A ADC-7
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-7-linker |
|
|
CN113549127A ADC-8
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-8-linker |
|
|
CN113549127A ADC-9
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-9-linker |
|
|
CN113549127A ADC-10
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-10-linker |
|
|
CN113549127A ADC-11
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-11-linker |
|
|
CN113549127A ADC-12
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-12-linker |
|
|
CN113549127A ADC-13
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-13-linker |
|
|
CN113549127A ADC-14
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-14-linker |
|
|
CN113549127A ADC-15
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-15-linker |
|
|
CN113549127A ADC-16
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-16-linker |
|
|
CN113549127A ADC-17
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-17-linker |
|
|
CN113549127A ADC-18
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-18-linker |
|
|
CN113549127A ADC-19
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-19-linker |
|
|
CN113549127A ADC-20
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-20-linker |
|
|
CN113549127A ADC-21
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-21-linker |
|
|
CN113549127A ADC-22
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-22-linker |
|
|
CN113549127A ADC-23
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-23-linker |
|
|
CN113549127A ADC-24
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-24-linker |
|
|
CN113549127A ADC-25
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-25-linker |
|
|
CN113549127A ADC-26
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-26-linker |
|
|
CN113549127A ADC-27
[12]
|
Undisclosed |
Undisclosed |
CN113549127A-ADC-27-linker |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
JS115
[13]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
HD-101
[14]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Ispectamab tazide
[15]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
LMB-75
[16]
|
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
|
|
LMB-70
[17]
|
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
|
|
BCMA-077
[18]
|
Duostatin 5.2 |
Microtubule (MT) |
Proprietary Concortis linker |
|
|
BCMA-024
[18]
|
Duostatin 5.2 |
Microtubule (MT) |
Proprietary Concortis linker |
References
